TTNP
Titan Pharmaceuticals
TTNP
TTNP
Delisted
TTNP was delisted on the 1st of October, 2025.
40 hedge funds and large institutions have $10.9M invested in Titan Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
40
Holders Change
-7
Holders Change %
-14.89%
% of All Funds
1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
7
Reduced
6
Closed
11
Calls
$736K
Puts
$3K
Net Calls
+$733K
Net Calls Change
-$369K
Top Buyers
1 |
BlackRock
New York
|
+$2.65M |
2 |
Renaissance Technologies
New York
|
+$296K |
3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$59.3K |
4 |
SG Americas Securities
New York
|
+$50K |
5 |
WAM
Wealthspire Advisors (Maryland)
Potomac,
Maryland
|
+$39K |